Transcatheter Technologies
Regensburg
About Transcatheter Technologies
TRANSCATHETER TECHNOLOGIES is developing a unique aortic valve implantation system that will increase the safety and durability of aortic valve implantation. The TRINITY repositionable transcatheter aortic valve system is at the forefront of next-generation transcatheter valve implantation technology. In the near future, transcatheter valve implantation will become the preferred therapy for aortic valve implantation, and TRANSCATHETER TECHNOLOGIES‘ goal is to provide the most advanced technology available.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.2M
- Funding stage: M&A
- Last round: Series B (Mar 2013)
- Website: transcatheter-technologies.com
- Phone: 490000000
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/transcatheter-technologies-3179351 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.